Table 2.
Inhibitory effects of siastatin B and DANA toward recombinant human NEU2 as to the natural substrate α2,3-sialyllactosea.
| Sample | pH | Sialic acid |
Relative rate of hydrolysis (%) | |
|---|---|---|---|---|
| Bound | Released | |||
| µmol | ||||
| NEU2 | 6.0 | 885 | 808 | 100 |
| 4.0 | 867 | 769 | 100 | |
| NEU2/siastatin Bb | 6.0 | 866 | 387 | 47.8 |
| 4.0 | 890 | 277 | 36.1 | |
| NEU2/DANAb | 6.0 | 855 | 336 | 41.6 |
| 4.0 | 882 | 494 | 64.3 | |
Substrate was incubated for 1 h under the standard assay conditions.
Siastatin B and DANA: final concentration 600 µM.